Zumiez (ZUMZ) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
2 Dec, 2025Executive summary
Fourth quarter comparable sales rose 5.9%, with gross margin up 190 basis points to 36.2%, and total sales at $279.2 million, slightly below initial guidance but above revised expectations.
Operating profit more than doubled to $20.1 million (7.2% of sales), and adjusted EPS increased 95% to $0.78, reversing a prior year net loss that included a $41.1 million goodwill impairment.
Full-year net sales grew 1.6% to $889.2 million, with comparable sales up 4% and net loss narrowing to $1.7 million ($0.09 per share), a significant improvement from the prior year.
Strategic initiatives included launching over 120 new brands, expanding private label to 28% of sales, and enhancing customer engagement through service and technology investments.
First quarter-to-date comparable sales up 4.3%, led by North America at 6.4%, while international comparable sales declined 3.7%.
Financial highlights
Q4 net sales were $279.2 million, down 0.9% year-over-year due to a shorter quarter; comparable sales rose 5.9%.
Q4 gross margin improved 190 basis points to 36.2%, driven by product margin and lower web shipping costs.
Q4 operating income was $20.1 million (7.2% of sales) versus a prior year loss, and net income was $14.8 million ($0.78 per share).
Year-end cash and marketable securities totaled $147.6 million, down from $171.6 million, mainly due to share repurchases and capital expenditures.
Full-year net sales grew 1.6% to $889.2 million; comparable sales up 4%.
Outlook and guidance
Q1 2025 sales expected between $179–$183 million (1–3% growth); comparable sales up 3–5%.
Q1 product margin expected flat to slightly down; operating loss projected between $16.5–$18.5 million; EPS loss $0.72–$0.82.
Full-year 2025: cautious optimism for sales and margin growth despite store closures; no specific annual guidance.
Nine new stores planned for 2025: up to 6 in North America, 2 in Europe, and 1 in Australia; capital expenditures expected at $14–$16 million.
Latest events from Zumiez
- Strong Q4 and FY25 results with margin gains and a new $40M buyback authorized.ZUMZ
Q4 202612 Mar 2026 - Gross margin rose to 29.3% as net loss narrowed and a $25M buyback was authorized.ZUMZ
Q1 20251 Feb 2026 - Q2 net sales rose 8.1%, gross margin expanded, and net loss narrowed on strong comps.ZUMZ
Q2 202522 Jan 2026 - Q3 net sales up 2.9%, comp sales up 7.5%, and margins improved; Q4 outlook remains strong.ZUMZ
Q3 202511 Jan 2026 - Q3 sales and EPS surged, with strong North America growth and positive Q4 outlook.ZUMZ
Q3 20267 Dec 2025 - Proxy covers director elections, executive pay, auditor ratification, and ESG priorities.ZUMZ
Proxy Filing1 Dec 2025 - Director elections, say-on-pay, and auditor ratification headline the June 2025 meeting.ZUMZ
Proxy Filing1 Dec 2025 - Q1 sales rose 3.9% with margin gains, narrowed loss, and new buybacks amid tariff risks.ZUMZ
Q1 202613 Nov 2025 - Q2 sales rose 1.9% with margin gains; North America led, and Q3 outlook is positive.ZUMZ
Q2 202620 Oct 2025